Overview

ASIS for Botox in Upper Limb Spasticity

Status:
Unknown status
Trial end date:
2017-06-01
Target enrollment:
Participant gender:
Summary
Botox act on nerve endings, yet there are no nerve endings inside the muscle, where they are typically injected. All nerves terminate on the fascia, where ASIS device can precisely deliver Botox by creating that subdermal bloodless space, between the skin and muscle. Thus enhancing and prolonging Botox's efficacy, at the same time prevent it's unnecessary adverse reactions and distant spread, especially since Botox has no reason to travel to the rest of the body any way.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
li nguyen
Treatments:
abobotulinumtoxinA
Botulinum Toxins, Type A
incobotulinumtoxinA
onabotulinumtoxinA